In this case, the tumor cells expressed CD79a and PAX-5, along with high expression of c-Myc and Bcl-2, which closely resembled the characteristics of “double-expressor DLBCL” in terms of pathological morphology (18). This evidence concerns the gene CD79A and neoplasm.